xni-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

星之心
2020-07-08

xni

Onconova Therapeutics Inc盘中异动早盘急速跳水5.58%报0.540美元

北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.

Onconova Therapeutics Inc盘中异动早盘急速跳水5.58%报0.540美元

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":949386199,"tweetId":"949386199","gmtCreate":1594148689311,"gmtModify":1705044011465,"author":{"id":3516396034245075,"idStr":"3516396034245075","authorId":3516396034245075,"authorIdStr":"3516396034245075","name":"星之心","avatar":"https://static.tigerbbs.com/5e56318f05277256f547366bf476bc94","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>xni</p></body></html>","htmlText":"<html><head></head><body><p>xni</p></body></html>","text":"xni","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/949386199","repostId":2046623376,"repostType":2,"repost":{"id":"2046623376","pubTimestamp":1593182465,"share":"https://www.laohu8.com/m/news/2046623376?lang=&edition=full","pubTime":"2020-06-26 22:41","market":"us","language":"zh","title":"Onconova Therapeutics Inc盘中异动 早盘急速跳水5.58%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2046623376","media":"自选股智能写手","summary":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.","content":"<html><body><article><p>北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。</p><p>最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。</p><p>机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。</p><p>Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc涨幅较大，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc较为活跃，换手率分别为155.76%、102.43%、62.38%，振幅较大的相关个股有Vaxart Inc、Citius Pharmaceuticals Inc、<a href=\"https://laohu8.com/S/CBLI\">克利夫兰生物实验室</a>，振幅分别为76.36%、57.41%、38.37%。</p><p>Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家在美国运营的临床阶段生物制药公司。 它专注于发现和开发主要用于治疗癌症的新型小分子产品候选物。 该公司创建了一个针对性试剂库，旨在对抗癌细胞重要的细胞途径。 它的候选产品为IV rigosertib，口服rigosertib +阿扎胞苷，IV Briciclib，Recilisib和ON123300。主要候选产品Rigosertib是一种小分子，可通过靶向RAS有效细胞途径来阻断信号传导。</p><p>（以上内容为自选股<a href=\"https://laohu8.com/S/5RE.SI\">智能</a>机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Onconova Therapeutics Inc盘中异动 早盘急速跳水5.58%报0.540美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOnconova Therapeutics Inc盘中异动 早盘急速跳水5.58%报0.540美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-06-26 22:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2020062622410779ef09c9&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2046623376","content_text":"北京时间2020年06月26日22时41分，Onconova Therapeutics Inc（ONTX.us）股票出现波动，股价急速跳水5.58%。截至发稿，该股报0.540美元/股，成交量228.582万股，换手率1.36%，振幅6.14%。最近的财报数据显示，该股实现营业收入52000.00美元，净利润-5.09百万美元，每股收益-0.03美元，毛利--，市盈率-2.35倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Onconova Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc涨幅较大，Vaxart Inc、Citius Pharmaceuticals Inc、Ibio Inc较为活跃，换手率分别为155.76%、102.43%、62.38%，振幅较大的相关个股有Vaxart Inc、Citius Pharmaceuticals Inc、克利夫兰生物实验室，振幅分别为76.36%、57.41%、38.37%。Onconova Therapeutics Inc公司简介：Onconova Therapeutics Inc是一家在美国运营的临床阶段生物制药公司。 它专注于发现和开发主要用于治疗癌症的新型小分子产品候选物。 该公司创建了一个针对性试剂库，旨在对抗癌细胞重要的细胞途径。 它的候选产品为IV rigosertib，口服rigosertib +阿扎胞苷，IV Briciclib，Recilisib和ON123300。主要候选产品Rigosertib是一种小分子，可通过靶向RAS有效细胞途径来阻断信号传导。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1},"isVote":1,"tweetType":1,"viewCount":387,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}